Adar Poonawalla, CEO of the Serum Institute of India, sold his entire stake in Panacea Biotec, amounting to 5.15 percent of the company, for Rs 118 crore in an open market deal on Monday.
The shares were picked by the Serum Institute of India (SII).
As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share, taking the total deal value to Rs 118.02 crore.
The shares were picked by SII at the same price, through a separate transaction.
As per shareholding data for March 2021 quarter, both Poonawalla and SII were public shareholders in the firm and held 5.15 per cent and 4.98 per cent stake in Panacea, respectively.
Shares of Panacea Biotec on Monday ended at Rs 384.9 apiece, 1.16 per cent higher over the previous close.
Separately, Sarda Mines sold shares worth Rs 227.66 crore in Jindal Steel and Power Ltd.
Over 52.74 lakh scrips were offloaded at the price of Rs 431.62 apiece.
Jindal Steel and Power stock on Monday ended 4.65 per cent higher at Rs 436.55.
Also Read: Delhi Police announces Info reward against Wrestler Sushil Kumar
Delhi Police declared a reward of Rs 1 lakh for details leading to the arrest of Sushil Kumar, India’s two-time Olympic medalist, in connection with the murder of Sagar Rana, a 23-year-old wrestler, in Delhi. For details about Sushil’s associate Ajay Kumar, a Rs 50 lakh cash reward has been revealed, continue reading… https://www.dishanews.com/sports/delhi-police-announces-info-reward-against-wrestler-sushil-kumar/
